India, Sept. 14 -- In what could be a miracle improving and saving thousands of lives across the globe, Russia's mRNA-based vaccine Enteromix has displayed 100% efficacy and safety in early clinical trials. Scientists say the breakthrough could mark a new chapter in the fight against aggressive cancers, offering patients hope where few options exist.

For decades, cancer has been one of humanity's most formidable enemies. Conventional treatments like chemotherapy and radiation, while sometimes life-saving, often take a heavy toll on the body - weakening patients and damaging healthy cells along with the malignant ones. Now, Russian researchers believe they may have found a gentler yet more powerful weapon.

A New Kind of Vaccine

Enteromi...